FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com
Stock analysts at StockNews.com began coverage on shares of FibroGen (NASDAQ:FGEN – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Other research analysts have also issued research reports about the stock. William Blair restated a “market perform” rating […]
Stock analysts at StockNews.com began coverage on shares of FibroGen (NASDAQ:FGEN – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Other research analysts have also issued research reports about the stock. William Blair restated a “market perform” rating […]
